Information for UK-based patients who have been prescribed RYBELSUS®

Welcome to once-daily RYBELSUS®

Information for patients who have been prescribed RYBELSUS®

RYBELSUS® is a medicine containing the active substance semaglutide, which is used to lower blood glucose (sugar) levels in adults (18 years and older) whose type 2 diabetes is not controlled well enough with diet and exercise. It can be used on its own when metformin (another medicine for diabetes) cannot be used, or in combination with other diabetes medicines, when the other medicines are not enough to control your blood sugar levels. It is important that you continue with your diet and exercise plan as agreed with your doctor, pharmacist or nurse.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed on this website or the patient information leaflet↗. You can also report side effects directly via the Yellow Card Scheme at↗. By reporting side effects you can help provide more information on the safety of this medicine.

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See↗ for how to report side effects.

The information provided on this site is intended for general information and education and is not intended to be a substitute for advice provided by your doctor or other qualified healthcare professionals.

Type 2 diabetes and the importance of blood sugar level control


Always take your dose as prescribed by your doctor

How RYBELSUS® works

Learn about how RYBELSUS® can be used as part of your type 2 diabetes management, to help you improve your control of blood sugar levels


Find out more about RYBELSUS®


How to take your dose as prescribed by your doctor

Possible side effects

Read more about possible side effects


Get answers to frequently asked questions

How to take RYBELSUS®

Build a good habit of taking RYBELSUS® the right way every day

UK21RYB00202 | November 2021